highperformr logo

AGTC's Overview

Total employees127
HeadquartersAlachua
Founded1999

Applied Genetic Technologies Corporation (AGTC) was a clinical-stage biotechnology company dedicated to developing and commercializing gene therapies for rare and debilitating ophthalmic, otologic, and central nervous system (CNS) diseases. AGTC's proprietary gene therapy platform aimed to deliver AAV (adeno-associated virus)-based therapies to provide long-lasting and transformative benefits to patients. Key programs focused on X-linked retinitis pigmentosa (XLRP) and achromatopsia. In November 2022, AGTC was acquired by Syncona Limited, a leading healthcare investment company, and now operates as a part of Syncona's portfolio, continuing its mission to advance genetic medicines.

Where is AGTC's Headquarters?

HQ Function

The Alachua headquarters served as the core for AGTC's research and development activities, clinical program oversight, manufacturing process development, and corporate operations.

Notable Features:

The facilities included state-of-the-art laboratories designed for gene therapy research, development, and small-scale cGMP manufacturing capabilities, located within Progress Corporate Park, fostering collaboration with other biotech entities.

Work Culture:

AGTC fostered a highly collaborative, science-driven, and patient-focused work culture. The environment encouraged innovation and dedication among its team of scientists, researchers, and professionals aiming to address significant unmet medical needs.

HQ Significance:

This location was pivotal for AGTC's scientific advancements, housing the intellectual capital and infrastructure necessary for developing its pipeline of AAV-based gene therapies from discovery through clinical trials.

Values Reflected in HQ: The headquarters embodied AGTC's commitment to scientific rigor, innovation in genetic medicine, and a focused mission to improve the lives of patients with rare diseases.

Location:

Prior to its acquisition, AGTC's global presence was primarily characterized by its international clinical trial activities for its gene therapy candidates. This involved collaborations with clinical sites and investigators in North America and Europe. The company also engaged with global regulatory bodies like the FDA and EMA. While its physical operational footprint was centered in the US, its research impact and patient recruitment efforts were international.

Street Address:

14193 NW 119th Terrace, Suite 10, Progress Corporate Park

City:

Alachua

State/Province:

Florida

Country:

USA

AGTC's Global Presence

Buying Intent Signals for AGTC

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of AGTC

As of April 2025, AGTC' leadership includes:

Sue Washer - President and Chief Executive Officer
Abraham Scaria, Ph.D. - Chief Scientific Officer (appointed April 2022)
Stephen W. Potter - Chief Business Officer
Jonathan I. Lieber - Chief Financial Officer (until August 2022)
Mark S. Shearman, Ph.D. - Former Chief Scientific Officer (until April 2022)

Investors of AGTC

AGTC has been backed by several prominent investors over the years, including:

Syncona Limited (Acquirer and Current Owner)
Invesco Ltd. (Pre-acquisition major institutional investor)
BlackRock Inc. (Pre-acquisition major institutional investor)
The Vanguard Group, Inc. (Pre-acquisition major institutional investor)
State Street Corporation (Pre-acquisition major institutional investor)
University of Florida Research Foundation (Founding/Early Funder)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

Applied Genetic Technologies Corporation (AGTC) was acquired by Syncona Ltd. in November 2022 and its operations were integrated. As a result, AGTC no longer functions as an independent company with its own executive team. Key leadership changes primarily occurred around the time of the acquisition, which falls outside the May 2023 - May 2024 period. No AGTC-specific executive hires or exits have been announced in the last 12 months under the AGTC banner.

Departures

N/A, No distinct AGTC executive departures in the last 12 months; roles were dissolved or transitioned as part of the Syncona acquisition in late 2022.

New Appointments:

N/A, No distinct AGTC executive appointments in the last 12 months; leadership is managed by Syncona post-acquisition.

Technology (Tech Stack) used by AGTC

Discover the tools AGTC uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

AGTC Email Formats and Examples

While AGTC is now part of Syncona, a common email format used by AGTC prior to its acquisition was likely [first_initial][last_name]@[company_domain].com. For example, jdoe@agtc.com. This is a standard convention in many corporations, particularly in the biotech sector.

[first_initial][last]@agtc.com

Format

swasher@agtc.com

Example

70%

Success rate

News and media

Syncona Press ReleaseNovember 28, 2022

Applied Genetic Technologies Corporation news title: Syncona Completes Acquisition of AGTC

Syncona Limited announced the successful completion of its acquisition of Applied Genetic Technologies Corporation (AGTC) for $0.73 per share in cash. This strategic move enhances Syncona's gene therapy portfolio with AGTC's AAV-based therapeutic candidates for rare ophthalmic diseases....more

Syncona Portfolio UpdateJuly 26, 2023

Applied Genetic Technologies Corporation news title: Syncona Highlights Progress in AGTC's Gene Therapy Programs

In its portfolio update, Syncona detailed ongoing development efforts for the gene therapy programs acquired from AGTC, including those for X-linked Retinitis Pigmentosa (XLRP) and Achromatopsia. Syncona emphasized its commitment to advancing these promising therapies towards clinical milestones....more

Syncona Full Year ResultsMay 23, 2024

Applied Genetic Technologies Corporation news title: Syncona's Annual Report Details Continued Investment in Former AGTC Assets

Syncona's full-year results for the period ending March 31, 2024, reported on the strategic execution across its portfolio, including the gene therapy assets from AGTC. The company noted continued investment and progress in the clinical development pathways for these programs, aiming to deliver value and new treatments for patients....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including AGTC, are just a search away.